Risk factors for venous thromboembolism (VTE) recurrences in Thai patients without cancer

References

• Oger E, EPI-GETBP Study Group. Incidence of venous thromboembolism: a community-based study in Western France. Thromb Haemost. 2000;83:657–660. doi: 10.1055/s-0037-1613887
   PubMed Web of Science ®Google Scholar
• Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. Arch Intern Med. 1991;151:933–938. doi: 10.1001/archinte.1991.00400050081016
   PubMed Web of Science ®Google Scholar
• Lee CH, Lin LJ, Cheng CL, et al. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. J Thromb Haemost. 2010;8:1515–1523. doi: 10.1111/j.1538-7836.2010.03873.x
   PubMed Web of Science ®Google Scholar
• Cheuk BLY, Cheung GCY, Cheng SWK. Epidemiology of venous thromboembolism in a Chinese population. Br J Surg. 2004;91:424–428. doi: 10.1002/bjs.4454
   PubMed Web of Science ®Google Scholar
• Jang MJ, Bang SM, Oh D. Incidence of venous thromboembolism in Korea: from the health insurance review and assessment service database. J Thromb Haemost. 2011;9:85–91. doi: 10.1111/j.1538-7836.2010.04108.x
   PubMed Web of Science ®Google Scholar
• Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000;160:761–768. doi: 10.1001/archinte.160.6.761
   PubMed Web of Science ®Google Scholar
• Hansson P-O, Sorbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis. Arch Intern Med. 2000;160:769–774. doi: 10.1001/archinte.160.6.769
   PubMed Web of Science ®Google Scholar
• Prandoni P, Lensing AW, Cogo A, et al. The long term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7. doi: 10.7326/0003-4819-125-1-199607010-00001
   PubMed Web of Science ®Google Scholar
• Baglin T, Douketis J, Tosetto A, et al. Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost. 2010;8:2436–2442. doi: 10.1111/j.1538-7836.2010.04022.x
   PubMed Web of Science ®Google Scholar
• Agnelli G, Prandoni P, Santamaria MG, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. N Engl J Med. 2001;345:165–169. doi: 10.1056/NEJM200107193450302
   PubMed Web of Science ®Google Scholar
• Schulman S, Lindmarker P, Holmström M, et al. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost. 2006;4:734–742. doi: 10.1111/j.1538-7836.2006.01795.x
   PubMed Web of Science ®Google Scholar
• Campbell IA, Bentley DP, Prescott RJ, et al. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. Br Med J. 2007;334:674. doi: 10.1136/bmj.39098.583356.55
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149:315–352. doi: 10.1016/j.chest.2015.11.026
   PubMed Web of Science ®Google Scholar
• Prandoni P. Cancer and venous thromboembolism. Clinical implications of strong association. Pathophysiol Haemost Thromb. 2006;35:111–115. doi: 10.1159/000093552
   PubMedGoogle Scholar
• Kyrle PA, Minar E, Bialonczyk C, et al. The risk of recurrent venous thromboembolism in men and women. N Engl J Med. 2004;350:2558–2563. doi: 10.1056/NEJMoa032959
   PubMed Web of Science ®Google Scholar
• Tosetto A, Iorio A, Marcucci M, et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost. 2012;10:1019–1025. doi: 10.1111/j.1538-7836.2012.04735.x
   PubMed Web of Science ®Google Scholar
• Baglin T, Luddington R, Brown K, et al. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003;362:523–526. doi: 10.1016/S0140-6736(03)14111-6
   PubMed Web of Science ®Google Scholar
• Kyrle PA, Rosendaal FR, Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet. 2010;376:2032–2039. doi: 10.1016/S0140-6736(10)60962-2
   PubMed Web of Science ®Google Scholar
• Christiansen SC, Cannegieter SC, Koster T, et al. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA. 2005;293:2352–2361. doi: 10.1001/jama.293.19.2352
   PubMed Web of Science ®Google Scholar
• Angchaisuksiri P, Atichartakarn V, Aryurachai K, et al. Risk factors of venous thromboembolism in Thai patients. Int J Hematol. 2007;86:397–402. doi: 10.1007/BF02983995
   PubMed Web of Science ®Google Scholar
• Angchaisuksiri P. Venous thromboembolism in Asia--an unrecognised and under-treated problem? Thromb Haemost. 2011;106:585–590. doi: 10.1160/TH11-03-0184
   PubMed Web of Science ®Google Scholar
• De Stefano V, Simioni P, Rossi E, et al. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica. 2006;91:695–698.
   PubMed Web of Science ®Google Scholar
• Rodger MA, Kahn SR, Wells PS, et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. Can Med Assoc J. 2008;179:417–426. doi: 10.1503/cmaj.080493
   PubMed Web of Science ®Google Scholar
• Eichinger S, Heinze G, Jandeck LM, et al. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation. 2010;121:1630–1636. doi: 10.1161/CIRCULATIONAHA.109.925214
   PubMed Web of Science ®Google Scholar
• Ensor J, Riley RD, Moore D, et al. Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE. BMJ Open. 2016;6:e011190. doi: 10.1136/bmjopen-2016-011190
   PubMed Web of Science ®Google Scholar
• White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med. 1998;128:737–740. doi: 10.7326/0003-4819-128-9-199805010-00006
   PubMed Web of Science ®Google Scholar
• Kim TM, Kim JS, Han SW, et al. Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea. Thromb Res. 2009;123:436–443. doi: 10.1016/j.thromres.2008.05.009
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306. doi: 10.1111/j.1538-7836.2006.01753.x
   PubMed Web of Science ®Google Scholar
• Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007;92:199–205. doi: 10.3324/haematol.10516
   PubMed Web of Science ®Google Scholar
• Miyata T, Maruyama K, Banno F, et al. Thrombophilia in East Asian countries: are there any genetic differences in these countries? Thromb J. 2016;14(Suppl 1):25. doi: 10.1186/s12959-016-0109-x
   PubMed Web of Science ®Google Scholar
• Akkawat B, Rojnuckarin P. Protein S deficiency is common in a healthy Thai population. J Med Assoc Thai. 2005;88(Suppl 4):S249–S254.
   PubMedGoogle Scholar
• Sirachainan N, Chuansumrit A, Sasanakul W, et al. R147w in PROC gene is a risk factor of thromboembolism in Thai children. Clin Appl Thromb Hemost. 2018;24:263–267. doi: 10.1177/1076029617709085
   PubMed Web of Science ®Google Scholar
• Kearon C, Iorio A, Palareti G. Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting. J Thromb Haemost. 2010;8:2313–2315. doi: 10.1111/j.1538-7836.2010.03991.x
   PubMed Web of Science ®Google Scholar